Literature DB >> 23370858

Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.

Mustafa Akif Sariyildiz1, Ibrahim Batmaz, Mahmut Budulgan, Mehtap Bozkurt, Levent Yazmalar, Ahmet Inanir, Tahsin Celepkolu, Remzi Çevik.   

Abstract

The aim of this study is to evaluate the relationship between the sleep quality and the disease-related variables, functional status, quality of life, and depressive symptoms in patients with systemic sclerosis (SSc). Forty-eight patients diagnosed with SSc and 42 healthy control subjects were enrolled in the study. The demographic and clinical characteristics of the patients such as the Raynaud's phenomenon, SSc subtype, digital ulcers, gastrointestinal and lung involvement, and disease activity were recorded. All patients were assessed using the short form 36 (SF-36) quality of life scale, the health assessment questionnaire and the beck depression inventory. Generalized pain and fatigue were assessed with the Visual Analoge Scale. For the evaluation of the sleep disturbance, the SSc and control groups were assessed with the help of the Pittsburgh Sleep Quality Index (PSQI). The patients with SSc had significantly higher scores in the subjective sleep quality, sleep latency, habitual sleep efficiency, sleep disturbance, daytime dysfunction domains, and in terms of the total PSQI score compared to the healthy control group (p < 0.05). According to the results of spearman's analysis, there was a significantly higher correlation between the generalised pain, fatigue, depressive symptoms, functional status, and physical score of the SF-36 and the sleep disturbance (p < 0.01). There was also a significantly lower correlation between the menopause status, dyspnoea, gastroesophageal reflux, dysphagia, the mental score of the SF-36, and the sleep disturbance (p < 0.05). The sleep quality is disturbed in patients with SSc. The lower quality of sleep is especially associated with the pain, fatigue, depressive symptoms, and functional status.

Entities:  

Mesh:

Year:  2013        PMID: 23370858     DOI: 10.1007/s00296-013-2680-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire.

Authors:  Ayse A Küçükdeveci; Hülya Sahin; Sebnem Ataman; Bridget Griffiths; Alan Tennant
Journal:  Arthritis Rheum       Date:  2004-02-15

2.  The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis.

Authors:  L Lasa; J L Ayuso-Mateos; J L Vázquez-Barquero; F J Díez-Manrique; C F Dowrick
Journal:  J Affect Disord       Date:  2000 Jan-Mar       Impact factor: 4.839

3.  Psychological adjustment to systemic sclerosis.

Authors:  V L Malcarne; H L Greenbergs
Journal:  Arthritis Care Res       Date:  1996-02

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes.

Authors:  F Kronenberg; L J Cote; D M Linkie; I Dyrenfurth; J A Downey
Journal:  Maturitas       Date:  1984-07       Impact factor: 4.342

6.  Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.

Authors:  Vijay Bodukam; Ron D Hays; Paul Maranian; Daniel E Furst; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2010-09-30       Impact factor: 7.580

7.  The impact of pain and symptoms of depression in scleroderma.

Authors:  Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis.

Authors:  Brett D Thombs; Marie Hudson; Suzanne S Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2008-04-15

10.  Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.

Authors:  Emi Matsuura; Akihide Ohta; Futoshi Kanegae; Yoshio Haruda; Osamu Ushiyama; Shuichi Koarada; Riko Togashi; Yoshifumi Tada; Noriaki Suzuki; Kohei Nagasawa
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

View more
  8 in total

1.  Familial Contributions to Self-Reported Sleep and Pain in Female Twins.

Authors:  Kathryn M Godfrey; Eric Strachan; Sheeva Mostoufi; Brian Poeschla; Annemarie Succop; Niloofar Afari
Journal:  Pain Med       Date:  2016-01       Impact factor: 3.750

2.  Reliability and validity of the Spanish version of the Pittsburgh Sleep Quality Index (PSQI) in patients with fibromyalgia.

Authors:  Fidel Hita-Contreras; Emilio Martínez-López; Pedro A Latorre-Román; Francisco Garrido; María A Santos; Antonio Martínez-Amat
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

Review 3.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

Review 4.  Comorbidity burden in systemic sclerosis: beyond disease-specific complications.

Authors:  Eleni Pagkopoulou; Alexandra Arvanitaki; Dimitrios Daoussis; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2019-07-12       Impact factor: 2.631

Review 5.  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors:  Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-09-15       Impact factor: 4.991

6.  Polysomnography findings and risk factors for sleep-disordered breathing in patients with systemic sclerosis.

Authors:  Ebru Çakır Edis; Renginar Mutlucan Eraslan; Osman Hatipoğlu
Journal:  Arch Rheumatol       Date:  2021-01-20       Impact factor: 1.472

Review 7.  State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases.

Authors:  Leopoldo Trieste; Sara Cannizzo; Ilaria Palla; Isotta Triulzi; Giuseppe Turchetti
Journal:  Front Med (Lausanne)       Date:  2022-09-23

8.  High Frequency of Fibromyalgia in Patients With Acne Vulgaris.

Authors:  Levent Yazmalar; Tahsin Çelepkolu; İbrahim Batmaz; Mustafa Akif Sariyildiz; Bilal Sula; Mahmut Alpayci; İsa An; Yahya Kemal Burkan; Haydar Uçak; Remzi Çevik
Journal:  Arch Rheumatol       Date:  2016-02-22       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.